Hyogo, Japan

Takashi Aoi

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Kobe University. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Aoi. Retrieved from https://idiyas.com/inventor/takashi-aoi-zrfntqaa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takashi Aoi: Innovator in Colon Cancer Research

Introduction

Takashi Aoi is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of cancer research, particularly in the study of colon cancer. His innovative work focuses on methods that enhance the understanding and treatment of this disease.

Latest Patents

Takashi Aoi holds a patent for a method for maintaining and amplifying colon cancer stem cells, as well as a method for inducing colon cancer organoids. This invention provides a crucial approach for the maintenance and expansion of colon cancer stem cells, which are vital for understanding the disease. Additionally, it offers a medicament screening system that utilizes these stem cells or organoids, paving the way for new therapeutic strategies.

Career Highlights

Aoi is affiliated with Kobe University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer treatment and understanding.

Collaborations

Some of his notable coworkers include Ryo Ishida and Michiyo Aoi, who collaborate with him in advancing research in this critical area.

Conclusion

Takashi Aoi's innovative methods in colon cancer research represent a significant advancement in the field. His contributions are essential for developing new treatment options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…